NeoStrata Launches Psorent Psoriasis Topical Treatment
Posted on: Wednesday, 6 February 2008, 09:01 CST
US-based NeoStrata has reported the launch of Psorent, an aesthetically advanced, steroid-free, topical treatment for psoriasis.
Psorent contains LCD (liquid carbonis distillate), which has shown efficacy against psoriasis symptoms in a novel, aesthetically advanced formulation and package that promotes high patient compliance. Psorent will be available without a prescription from dermatologists beginning March 2008.
Barbara Green, vice president for technology and clinical affairs at NeoStrata, said: "With the launch of Psorent, physicians will be able to offer patients a novel psoriasis treatment that reduces the unpleasant aspects of traditional coal tar therapy, resulting in high patient compliance without compromising efficacy or safety. Psorent's effective and unique fast-absorbing solution applies easily and conveniently making it an ideal first-line therapy for the vast majority of psoriasis patients."
Source: Datamonitor
Related Articles
- Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform
- Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis
- Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis
- Understanding Psoriasis
- New Drug Relieves Psoriasis
- Recent Insights into the Immunopathogenesis of Psoriasis Provide New Therapeutic Opportunities
- New Weapons in Fight Against Psoriasis
- Breakthrough Drug for Psoriasis Sufferers
- Psoriasis Drug Goes Beyond Creams
User Comments (1)
| 1. |
Posted by Katrina P on 02/06/2008, 13:05 This is great! As a psoriasis patient, its good to have something out there that doesn't need a prescription, and good to know that there is something new out there to try. |

RSS Feeds